Ravinder Dhawan

Ravinder is Vice President and head of Oncology Product Line within Center for Observational and Real World Evidence (CORE) and has responsibility for generating evidence to support value proposition for Merck’s oncology products. Ravinder has over 20 years of experience in outcomes research, market access and pharmaceutical pricing. Prior to joining Merck recently, he served as head of oncology outcomes group at Sanofi and was head of global market access in oncology and Metabolics at Johnson & Johnson Pharmaceutical for over 10 years. Earlier in his career, Ravinder taught Health Economics at the University of Western Ontario in Canada and University of Connecticut in the US. During his career, he has developed wealth of experience in dealing with reimbursement and access issues with various health technology assessment (HTA) agencies around the globe. Ravinder has authored over 50 abstracts, posters and publications in health economics and outcomes research.

[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]